Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-06-18
1986-08-05
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530354, C08L 8904, C08L 8906, C09H 700
Patent
active
046043799
ABSTRACT:
Peritoneal dialysis solution may have an osmotic agent as a partial or complete substitute to the conventional dextrose. The osmotic agent is gelatin chemically cross-linked to suppress gelation.
REFERENCES:
patent: 3057782 (1962-10-01), Linder et al.
patent: 4339433 (1982-07-01), Kartinos et al.
Publication entitled Modified Gelatins as Plasma Substitutes; Bibl. Haemat., No. 33 (Karger, Basel/New York 1969), pp. 55-125.
Nolph Karl D.
Twardowski Zbylut J.
Curators of the University of Missouri
Ellis Garrettson
Flattery Paul C.
Ryan Daniel D.
Schain Howard E.
LandOfFree
Dialysis solutions containing cross-linked gelatin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dialysis solutions containing cross-linked gelatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dialysis solutions containing cross-linked gelatin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-969162